TD Cowen Reiterates Buy on Boston Scientific, Maintains $56 Price Target

Benzinga · 3d ago
TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $56 price target.